Virtu Financial’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,109
Closed -$31K 1639
2025
Q4
$31K Buy
+1,109
New +$43.5K ﹤0.01% 1360
2024
Q2
Sell
-600
Closed -$103K 1317
2024
Q1
$103K Buy
+600
New +$74.5K 0.01% 920
2023
Q2
Sell
-206
Closed -$28K 1515
2023
Q1
$28K Buy
+206
New +$37.1K ﹤0.01% 1176
2022
Q3
Sell
-292
Closed -$42K 1729
2022
Q2
$42K Sell
292
-493
-63% -$78.5K ﹤0.01% 1168
2022
Q1
$196K Buy
+785
New +$328K 0.01% 788

Other funds holding BCAB

Virtu Financial's BCAB Position: Q1 2026 in Review

Virtu Financial sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 1,109 shares — an estimated $31K sold.

Virtu Financial first reported a position in BCAB in Q1 2022 and held it in 5 quarters. The position peaked at $196K in Q1 2022. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Virtu Financial reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 1,109 BioAtla shares in Q1 2026, an estimated $31K.
  • Virtu Financial first reported a position in BioAtla in Q1 2022 and held it in 5 quarters.
  • Virtu Financial's BioAtla position peaked at $196K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.